Why are missing quality of life data a problem in clinical trials of cancer therapy?

Statistics in Medicine
D L FaircloughV Chang

Abstract

Assessment of health related quality of life has become an important endpoint in many cancer clinical trials. Because the participants of these trials often experience disease and treatment related morbidity and mortality, non-random missing assessments are inevitable. Examples are presented from several such trials that illustrate the impact of missing data on the analysis of QOL in these trials. The sensitivity of different analyses depends on the proportion of assessments that are missing and the strength of the association of the underlying reasons for missing data with disease and treatment related morbidity and mortality. In the setting of clinical trials of cancer therapy, the assumption that the data are missing completely at random (MCAR) and analyses of complete cases is usually unjustified. Further, the assumption of missing at random (MAR) may also be violated in many trials and models appropriate for non-ignorable missing data should be explored. Recommendations are presented to minimize missing data, to obtain useful documentation concerning the reasons for missing data and to perform sensitivity analyses.

Citations

Feb 20, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Marlene H FrostPing Yang
Dec 16, 2011·Leukemia & Lymphoma·Monica ElseUNKNOWN UK National Cancer Research Institute (NCRI) Chronic Lymphocytic Leukaemia Trials Group
Feb 7, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Rebecca L Mercieca-BebberFabio Efficace
Jul 9, 2008·Disability and Rehabilitation·Alan S Rigby
Apr 25, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Crispin JenkinsonRay Fitzpatrick
Mar 15, 2011·Journal of Pain and Symptom Management·Andrea L ChevillePing Yang
Apr 24, 2007·Contemporary Clinical Trials·Lehlohonolo J Mathibe
Mar 14, 2007·Research in Social & Administrative Pharmacy : RSAP·Christine BonoBruce Vogel
Sep 11, 2007·Biometrics·Constantine E FrangakisEllen MacKenzie
May 11, 2011·International Journal of Methods in Psychiatric Research·Ulrike GrittnerMatthias Wicki
May 4, 2013·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·K D CoulmanJ M Blazeby
Oct 15, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Hiroyuki KatohHirohiko Tsujii
Apr 8, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Linda S YangDavid L Morris
Dec 13, 2006·Journal of Clinical Epidemiology·Varda ShalevAnthony D Heymann
May 9, 2006·Contemporary Clinical Trials·M JandaUNKNOWN LACE Trial Committee
Nov 29, 2005·Current Problems in Cancer·Jefrey L Huntington, Amylou Dueck
Nov 12, 2013·European Urology·Fabio EfficaceUNKNOWN EORTC Quality of Life Group (Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Project)
Jun 24, 2009·Health and Quality of Life Outcomes·Shona FieldingCraig R Ramsay
Jan 16, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Patricia MarinoUNKNOWN PEGASE Group
Feb 25, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Élodie de BockVéronique Sébille
Oct 18, 2003·American Heart Journal·Sean C BeinartJohn S Rumsfeld
May 4, 2006·Journal of the National Cancer Institute·Joseph Pater, Wendy Parulekar
Nov 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeff A SloanUNKNOWN National Cancer Institute
Sep 28, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary W Donaldson, Carol M Moinpour
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Louise BordeleauPamela J Goodwin
Sep 29, 2015·Journal of Gastroenterology and Hepatology·Hiroyuki SugimotoYoshiki Hirooka
Nov 30, 2016·Clinical Orthopaedics and Related Research·Bryce A BasquesJonathan N Grauer
Oct 19, 2017·European Heart Journal. Quality of Care & Clinical Outcomes·Salla OinasmaaAnna-Maija Tolppanen
Mar 19, 2004·Journal of Biopharmaceutical Statistics·Rajeshwari SridharaDonna J Griebel
Jun 19, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Patricia J HollenCynthia N Rittenberg
Jul 22, 2004·Pediatric Blood & Cancer·Sean PhippsShesh N Rai
Nov 28, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Amélie AnotaFranck Bonnetain
Jan 30, 2016·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Ines RombachÓrlaith Burke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.